Literature DB >> 3004064

[Effect of acute and chronic deprivation of catecholaminergic system activity induced by 6-hydroxydopamine on the behavior of the rat].

E A Gromova, T P Semenova, N I Grishchenko.   

Abstract

On 202 male rats of Wistar line, a study was carried out of the effect of chronic and acute deprivations of the brain CA-systems activity resulting from administration of 6-OHDA on investigating behaviour and learning. Chronic deprivation of CA-systems activity by neonatal administration of 6-OHDA (100 mg/kg subcutaneously) and their acute deprivation by intracerebral administration of 6-OHDA to adult rats (150 mkg in each lateral ventriculus) was accompanied by similar deep changes of behaviour. Both forms of deprivation reduced the investigating activity of the animals in the open field. In both cases, the above 6-OHDA dozes sharply impeded the learning of animals with emotionally negative reinforcement, with no significant influence on learning with emotionally positive reinforcement. Both forms of deprivation of CA-systems activity weakened the reaction of frustration elicited by a sharp reduction of food reinforcement.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3004064

Source DB:  PubMed          Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova        ISSN: 0044-4677            Impact factor:   0.437


  2 in total

1.  Compensation for behavioral disorders due to administration of 6-hydroxy-dopamine in transplantation of embryonic locus coeruleus tissue in rats.

Authors:  T P Semenova; A G Bragin; N I Grishchenko; I V Nesterova; O S Vinogradova; E A Gromova
Journal:  Neurosci Behav Physiol       Date:  1989 Sep-Oct

2.  Terminal uridyltransferase 7 regulates TLR4-triggered inflammation by controlling Regnase-1 mRNA uridylation and degradation.

Authors:  Chia-Ching Lin; Yi-Ru Shen; Chi-Chih Chang; Xiang-Yi Guo; Yun-Yun Young; Ting-Yu Lai; I-Shing Yu; Chih-Yuan Lee; Tsung-Hsien Chuang; Hsin-Yue Tsai; Li-Chung Hsu
Journal:  Nat Commun       Date:  2021-06-29       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.